197 results on '"Gau, Churn-Shiouh"'
Search Results
2. Analysis of refuse-to-file policy for generic drug application in Taiwan
3. Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues
4. Regulatory considerations for generic products of non-biological complex drugs
5. Characterization of patients with duplicated z-hypnotic use: A population-based study in Taiwan
6. Development of the risk-based, phased-in approach for the international harmonization of the regulation of container closure systems for drugs in Taiwan
7. The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan
8. The challenges and opportunities in using real-world data to drive advances in healthcare in East Asia: expert panel recommendations
9. Suboptimal Duration of Granulocyte Colony–stimulating Factor Use and Chemotherapy-induced Neutropenia in Women Diagnosed With Breast Cancer
10. Injury-Proneness of Youth with Attention-Deficit Hyperactivity Disorder: A National Clinical Data Analysis in Taiwan
11. Ten-year trend in prescriptions of z-hypnotics among the elderly: A nationwide, cross-sectional study in Taiwan
12. Injury-proneness of youth with attention-deficit hyperactivity disorder: A national clinical data analysis in Taiwan
13. APEC Workshop Report of Good Review Practices on Medical Products
14. Patient Involvement in the Health Technology Assessment Process in Taiwan
15. Science of Safety Topic Coverage in Experiential Education in US and Taiwan Colleges and Schools of Pharmacy
16. Impact of Ezetimibe Coadministered With Statins on Cardiovascular Events Following Acute Coronary Syndrome: A 3-Year Population-Based Retrospective Cohort Study in Taiwan
17. The impact of The Rare Disease and Orphan Drug Act in Taiwan
18. Statistics, Quality Review Issues, and Beyond for Generic Drug Applications in Taiwan
19. Risk of Bladder Cancer in Diabetic Patients Treated with Rosiglitazone or Pioglitazone: A Nested Case–Control Study
20. Age, Dementia and Care Patterns after Admission for Acute Coronary Syndrome: An Analysis from a Nationwide Cohort under the National Health Insurance Coverage
21. Interfacial properties of Pluronics and the interactions between Pluronics and cholesterol/DPPC mixed monolayers
22. An Experimental Model of Regulatory Science in Asia: Center for Drug Evaluation in Taiwan
23. The influence of estimated creatinine clearance on plasma homocysteine in hypertensive patients with normal serum creatinine
24. Lessons learned from the reimbursement policy for immune checkpoint inhibitors and real-world data collection in Taiwan
25. Correction: Valuation of the EQ-5D-5L in Taiwan.
26. Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan
27. Using real‐world evidence for pharmacovigilance and drug safety‐related decision making by a resource‐limited health authority: 10 years of experience in Taiwan
28. Clinical Trials in Global Drug Developments
29. Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case-control study
30. Interactions of Pluronics with phospholipid monolayers at the air–water interface
31. Waist-to-hip ratio correlates with homocysteine levels in male patients with coronary artery disease
32. Usage of the claim database of national health insurance programme for analysis of cisapride-erythromycin co-medication in Taiwan†
33. Interaction between Anticonvulsants and Human Placental Carnitine Transporter
34. Outcomes and Impacts of 10-Year HTA Implementation in Taiwan
35. Valuation of the EQ-5D-5L in Taiwan
36. Lessons learned from the reimbursement policy for immune checkpoint inhibitors and real-world data collection in Taiwan.
37. PP025 Thrombopoietin Receptor Agonist For Treatment Of Adults With Chronic Immune Thrombocytopenic Purpura
38. Demographics and Long-Term Outcome of Incident Immune Thrombocytopenic Purpura: A Twelve-Years Nationwide Population-Based Study in Taiwan
39. Affordable health technology assessment in Taiwan: A model for middle-income countries
40. Epidemiology, clinical profile and treatment patterns of venous thromboembolism in cancer patients in Taiwan: a population-based study
41. Regulatory status of drug master file in Taiwan 2009–2011
42. Sex Differences in the Treatment and Outcome of Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention: A Population-Based Study
43. Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
44. Use of Antipsychotics and Risk of Cerebrovascular Events in Schizophrenic Patients
45. Secular trends of ADHD and developmental delay in Taiwanese children with epilepsy: A 13-year National Health Insurance data retrospective analysis
46. Prediction of ADHD to Anxiety Disorders
47. Cardiovascular Events and Methylphenidate Use in Taiwan
48. Value of preapproval safety data in predicting postapproval hepatic safety and assessing the legitimacy of class warning
49. Reply to Singh on the Prospective Study of Hepatitis
50. A Prospective Study of Hepatitis During Antituberculous Treatment in Taiwanese Patients and a Review of the Literature
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.